Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group Plc LSE:DEMG London Ordinary Share GB0059337583 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 2.00 1.90 2.10 2.00 2.00 2.00 321,088 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 4.3 -0.2 -0.0 - 10

Deltex Medical Share Discussion Threads

Showing 21826 to 21848 of 21850 messages
Chat Pages: 874  873  872  871  870  869  868  867  866  865  864  863  Older
DateSubjectAuthorDiscuss
01/3/2021
18:40
Schloo Thanks for that.
janatha
01/3/2021
16:58
>> gbenson Well the results will be awful as we know from the trading statement so I am not sure they are of any relevance to the take over. It's just a matter of when......IMHO!
nobbygnome
01/3/2021
16:14
If last years anything to go by full year results are due in about 2 months time - end of April. If there are companies looking to buy DEMG do they wait until the results are out, or strike before to get more of a bargain on the price, anyone any thoughts?
gbenson1
01/3/2021
15:39
Another interesting social media post from Deltex/Andy at hxxps://www.deltexmedical.com/news/only-odm-has-the-precision-concludes-new-study/ The study is rather arcane but it clearly differentiates between ODM which can and does detect haemodynamic changes that have a big bearing on patient outcomes and long term prospects and the PPWA (as used by Edwards and Lidco, just bought by Masimo) and PVI (recently bought by Baxter) technologies which can not and do not detect these critical changes The big boys, Edwards, Masimo, Getinge & Baxter have all spent vast sums backing horses that are not fit for purpose. One of them will buy DEMG before much longer: lets hope they do so against stiff competition from one or more of the others
schloo
26/2/2021
17:17
Trying to keep quieter on here having had my wrists slapped both on and off lineBut, they had good momentum for a spell there and totally failed to push out any news. As a minimum they could put a date out for results announcement and comment on surgical volumes. Amateurish!MrC
mrc2u
26/2/2021
16:27
Terrible week, seems the sellers are in the ascendancy!
gbenson1
25/2/2021
11:57
Huge backlog of elective surgeries to clear.
janatha
23/2/2021
07:08
Good news re recovery in surgical volumes from this morning's newsfeed: expect this to come through in DEMG's H1 performance "Elective surgeries, which dropped significantly in the US and European Union at the outset of the COVID-19 pandemic, are rebounding, and further growth is possible, according to an IQVIA MedTech Pulse Survey of hospital surgeons and executives in both regions conducted in monthly waves between March 24 and December 8, 2020. Concerns over shortages of personal protective equipment for health care professionals and critical patient care equipment led to temporary pauses in elective procedures when the pandemic began."
schloo
19/2/2021
13:16
Nice find schloo, I follow Andy Mears on twitter but he hasn't posted anything for almost a year!
gbenson1
19/2/2021
13:01
Interesting social media post just now from Andy copied below. Looks like the competition will have to stop the fantasy that completely different approaches to a problem are the same The regulators are, finally, catching up with this scam: scandalous really. I wonder how many hundreds of thousands of people have died early because NICE et al didn't have the intellectual rigour (aka balls) to actually assess the evidence bases for LID, Edwards, Cheetah and all? This is why they should buy DEMG and why it should be for a big price and why it should be soon "Tired of your evidence base being plagiarised by your competitor? Change is coming! Deltex, like so many other Life Science companies, is transitioning from MDD to MDR. In completing our Clinical Evaluation Report we finally see some upside to the increasing regulatory burden and cost. Here’s why: MDR will have a positive impact on us and many companies like us who continually have their clinical evidence plagiarised by competitors who claim ‘equivalence’ to support their own technologies… despite none existing. MDR clearly defines clinical equivalence as ‘the device is of similar design; is used under similar conditions of use; has similar specifications and properties including physicochemical properties such as intensity of energy, tensile strength, viscosity, surface characteristics, wavelength and software algorithms; uses similar deployment methods, where relevant; has similar principles of operation and critical performance requirements’. Therefore to those companies who have historically used the evidence base conducted on the Oesophageal Doppler Monitor to validate their own, very fundamentally different technologies, it’s now time to invest in building your own specific clinical evidence base. #EvidenceBasedMedicine #MDR #ODM #ABHI #NICE #lifescience"
schloo
19/2/2021
12:50
Spread really tight today 2.13 to sell and 2.20 to buy, 2nd day in a row they've dropped the price to 2.20 on the open without any trades for whatever reason? Somethings going on!
gbenson1
17/2/2021
15:08
Hopefully we get an offer soon.
bugsbunny10
17/2/2021
12:49
another million or so would take it through 2.6p.
janatha
17/2/2021
09:11
Lidco? But then I'm confused because they no longer exist....
nobbygnome
17/2/2021
09:01
Sorry don't get what you mean Loserco?
nobbygnome
17/2/2021
08:57
Look like some former Loserco shareholder trying to exit his large!! holding?
gbenson1
16/2/2021
16:01
Cantors are up and down like a yo-yo; now back to 2.2p bid with apparently little bought again.
nobbygnome
16/2/2021
13:47
Ah well 500,000 buy is better than nothing, nice to see a spike up in the Sp.
gbenson1
16/2/2021
12:56
Interesting move up today on apparently little trade. A big delayed buy to come?
nobbygnome
16/2/2021
09:06
Hopefully not long now until sellout.
bugsbunny10
12/2/2021
14:42
If mms want more stock they will need to lift share price by another 7-10%. Nobody selling at these levels.
janatha
11/2/2021
08:12
So the real quotes are 2.175 bid and 2.225 offered so actually quite tight. The MMs play a funny old game sometimes....
nobbygnome
10/2/2021
13:02
Anything less than 8p will be, literally, a sell out8p min, 12p max but need to make changes fast to get to top of range and do not show any appetite to do so
mrc2u
Chat Pages: 874  873  872  871  870  869  868  867  866  865  864  863  Older
ADVFN Advertorial
Your Recent History
LSE
DEMG
Deltex Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210302 20:43:49